Forte Biosciences Inc.
FBRX
$11.91+0.34 (+2.94%)
Aug 18, 2025, 4:00 PM
Financials
| 52Week High | 28.68 | 52Week Low | 4.11 |
| Beta | 2.92 | Current Ratio Annual | 6.76 |
| Current Ratio Quarterly | 5.22 | Market Cap | 55.89M |
| Net Profit Margin TTM | -158,775.00 | Operating Margin TTM | -150,175.00 |
| Price To Book | 1.45 | Price To Sales TTM | 1,397.32 |
| Quick Ratio Annual | 6.46 | Quick Ratio Quarterly | 5.13 |
| Return On Assets TTM | -114.25 | Return On Equity TTM | -149.15 |
| Return On Investment TTM | -149.15 | Revenue Growth3Y | -7.17 |
| Revenue Growth5Y | -7.79 | Revenue Growth Quarterly Yoy | 0.00 |
| Revenue Growth TTMYoy | -99.78 | Revenue Per Share TTM | 0.03 |
13F Aggregates
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 27 | 1 | 0 | 1 | 0 | 2 | 4.28M | $97.10M |
| Mar 31, 2025 | 30(+11%) | 5(+400%) | 2(+%) | 8(+700%) | 4(+%) | 12(+500%) | 5.03M(+18%) | $39.32M(-60%) |
| Jun 30, 2025 | 33(+10%) | 7(+40%) | 4(+100%) | 15(+88%) | 4 | 5(-58%) | 9.81M(+95%) | $127.06M(+223%) |